Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Total Non-Current Liabilities: 2010-2018

Historic Total Non-Current Liabilities for EyePoint Pharmaceuticals (EYPT) over the last 4 years, with Jun 2018 value amounting to $40.2 million.

  • EyePoint Pharmaceuticals' Total Non-Current Liabilities rose 71.06% to $59.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $59.9 million, marking a year-over-year increase of 71.06%. This contributed to the annual value of $40.2 million for FY2018, which is 659.98% up from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Total Non-Current Liabilities stood at $40.2 million for FY2018, which was up 659.98% from $5.3 million recorded in FY2017.
  • EyePoint Pharmaceuticals' Total Non-Current Liabilities' 5-year high stood at $40.2 million during FY2018, with a 5-year trough of $5.3 million in FY2017.
  • In the last 2 years, EyePoint Pharmaceuticals' Total Non-Current Liabilities had a median value of $22.7 million in 2017 and averaged $22.7 million.
  • Data for EyePoint Pharmaceuticals' Total Non-Current Liabilities shows a peak YoY soared of 659.98% (in 2018) over the last 5 years.
  • Yearly analysis of 2 years shows EyePoint Pharmaceuticals' Total Non-Current Liabilities stood at $5.3 million in 2017, then soared by 659.98% to $40.2 million in 2018.